Related Experiment Video

Updated: Dec 8, 2025

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

5.8K

The E2 ubiquitin-conjugating enzyme UbcH5c: an emerging target in cancer and immune disorders

Yuan Zhou1, Runzhe Chen2, Xiaofang Luo3

  • 1College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.

Drug Discovery Today
|September 18, 2020
PubMed

Insights

UbcH5c, a ubiquitin-conjugating enzyme, regulates key signaling pathways and is implicated in cancer and immune disorders. Inhibiting UbcH5c shows promise as a cancer therapy strategy, despite challenges.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Signaling

Background:

  • Ubiquitination is a vital post-translational modification (PTM) regulating protein stability and activity.
  • UbcH5c, a ubiquitin-conjugating enzyme (E2), targets numerous proteins and influences critical pathways like NF-κB and p53.
  • Abnormal UbcH5c expression is linked to human cancers and immune disorders, suggesting its role in disease initiation and progression.

Purpose of the Study:

  • To review the structure, activity, and signaling pathways of UbcH5c.
  • To explore the relevance of UbcH5c in cancer and immune disorders.
  • To discuss UbcH5c inhibition as a potential cancer therapeutic strategy.

Main Methods:

  • Literature review focusing on UbcH5c.
  • Analysis of UbcH5c's role in cellular signaling.
  • Integration of data on UbcH5c's involvement in disease pathogenesis.

Main Results:

  • UbcH5c plays a significant role in modulating protein ubiquitination and downstream signaling.
  • Dysregulation of UbcH5c is associated with the development and progression of various cancers and immune diseases.
  • UbcH5c's involvement in essential cellular processes highlights its therapeutic potential.

Conclusions:

  • Understanding UbcH5c's function is crucial for deciphering its role in disease.
  • Targeting UbcH5c presents a promising avenue for cancer therapy development.
  • Further research is needed to overcome challenges associated with UbcH5c-targeted therapies.

More Related Videos

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

2.9K
A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants06:35

A Scalable, Cell-Based Method for the Functional Assessment of Ube3a Variants

Published on: October 10, 2022

2.2K

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.4K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.3K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.4K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K